- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- Real estate platform acquires Florida MOB for $28.5M
- Nation’s oldest hospital opens museum
- 5 medical device recalls to know
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- ASHP to connect with schools in efforts to expand pharmacy workforce
- Missouri system expands interventional cardiology services
- The patient safety ‘iceberg’: What reporting dashboards miss
- The week in hospital M&A
- CDC classifies hantavirus outbreak as level 3, five states on the watch
- Willis Knighton Health taps AI scribe vendor
- ‘Financially and operationally unsustainable’: North Carolina hospital to drop Blue Cross Blue Shield, UnitedHealthcare Medicare Advantage plans
- Healthcare adds 37,300 jobs in April: 4 things to know
- AI struggles with basic data tasks for hospital administrators: Study
- Why have the physicians gone? 10 stats on early career departure
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- Allstate accuses Chicago ASC of running fraud scheme
- 5 DSOs making headlines
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- Exposure Therapy Can Successfully Ease Peanut Allergies
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Revisiting Pharma’s tariff reality
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- New York system opens outpatient pavilion
- What cardiology ASCs still haven’t mastered
- Texas dental practice relocates into 6K-square-foot facility
- Surgery Partners opens 9 ASCs in 12 months amid ‘fickle’ M&A market
- Medit launches global orthodontics division, acquires California training institute
- What’s going on behind ASC de novo development?
- Pennsylvania enacts dental faculty bill
- Dental industry eyes increased payer oversight, transparency: 4 updates
- Dr. Michael Durbin named president of the American Association of Orthodontists
- Arkansas dental school launches partnership with children’s hospital
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Straine Dental unifies 3 operating companies under single brand
- Is dentistry losing its spark?
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’ for hospital medicine
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Wisconsin releases statewide mental health action plan: 4 things to know
- Alabama behavioral health provider opens outpatient clinic
- Oscar Health's profit hits $679M, membership rises in Q1
- Kaiser Permanente eases ‘last mile to licensure’ for mental health workers
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- Cannabis most commonly microdosed substance in US: Study
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- Lilly to invest $4.5B more into massive Indiana manufacturing complex
- CVS execs say company on track to meet MA margin goals by 2028
- Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- California hospitals sue Anthem over out-of-network care policy
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- UnitedHealthcare to reduce prior auth requirements by 30%
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
Dr. Deane Waldman argues from bitter personal experience that wait times are the true measure of health care system effectiveness, not the insured percentage of the population or the patients' costs of health care services that politicians and journalists focus on:
https://spectator.org/wait-times-for-medical-care-matter/
Wait Times for Medical Care Matter
The amount of time it takes to see a physician is the best measure of health care effectiveness.
By Deane Waldman, M.D. - June 22, 2024I am sick and tired of reading headlines about the uninsured rate (i.e. the percentage of people who don’t have health insurance). When it’s down, pundits say Obamacare is working. When it’s up, Democrats claim it is Republicans’ fault for ruining healthcare. Americans care only because that’s what is shouted in their ears and constantly before their eyes: uninsured rate, uninsured rate.
Maximum average wait times for care increased after the ACA to a medically dangerous 122 days for a primary care appointment.
The goal of healthcare is not to have everyone insured. A healthcare system exists solely so provide the services of a medical professional. Not the promise of care but the reality of care, when patients need it.
Complicit media has successfully sold snake oil. They make us believe that coverage — a health insurance policy — equals medical care. If you have the former, you will get the latter. Evidence proves precisely the opposite.
First, people who have no insurance get care through the Emergency Medical Transport and Labor Act of 1986. EMTALA requires hospitals to provide urgent or emergent care for all persons regardless of whether the patient has insurance or does not, i.e., whether the hospital and doctors will be paid for care provided, or not. (READ MORE from Deane Waldman: Government Health Coverage for Illegals is a Bad Idea)
Second, people who have insurance, particularly government-provided insurance, often wait so long for care they die while waiting in line. Such death-by-queue has been reported in Medicaid enrollees as well as veterans covered by Tricare.
The false promise of coverage equals care is exploded by the seesaw effect. As the number of Americans with government insurance goes up, access to care goes down! This inverse (and adverse) consequence is proven by two facts:
1) As Obamacare expanded the Medicaid rolls, fewer doctors were willing to accept these patients for care. Approximately 30 percent are considering early retirement. More demand (for care) with less supply (fewer care givers) produces the seesaw effect.
2) Maximum average wait times for care increased after the ACA to a medically dangerous 122 days for a primary care appointment.
Another metric commonly thrown at the public is cost. That medical costs are too high is obvious by simple observation, by painful direct experience, and by the number of bankruptcies induced by medical bills. When Washington fixes prices, viz., for drugs in Biden’s falsely titled Inflation Reduction Act of 2022, they claim to “make healthcare affordable for all Americans.” Like the mirage that coverage equals care, fixing prices does not make medical care more accessible, in fact, just the opposite.
Price fixing by the government, no matter what is being price-fixed, invariably produces shortages and low quality. History has proven this economic fact. Recall the long lines of people in the U.S.S.R. waiting for “free” shoes, toilet paper, and medical care. Furthermore, fixing low prices for medicines will force pharmaceutical companies to cease research and development. So no new medical miracle drugs. Had Washington fixed drug prices back in the 1970s, today it is likely that children with leukemia would die instead of their 90+ percent cure rate.
Americans are already suffering from price fixing in medical professional services. What the public sees as exorbitant doctor’s charges make great targets for price fixing or even price transparency advocates. A physician’s charges are meaningless in the real world. Medicaid and Medicare issue “allowable reimbursement schedules,” which are lists of predetermined payments for care services, usually a small fraction of the actual charges. Insurance companies and health plans generally follow these schedules when contracting with physicians. And since Washington prohibits physicians from seeking the unpaid balance from patients, doctors are paid whatever Washington says, not what they charged.
When asked why they are refusing to see new Medicaid patients, doctors point to two factors: the low reimbursement schedules, often below their cost-of-doing-business, and the time-wasting, costly regulatory burden. Price fixing strikes again — hurting, not helping, We the Patients.
To offer the public a useful and accurate measure of how well our healthcare system is doing, do not offer the uninsured rate or fixed (low) prices for care. Show us the maximum wait times to get care. The title of an article in the British Medical Journal shows the danger patients face, “Every month delayed in cancer treatment can raise risk of death by around 10%.” Imagine what the current four-month delay is doing. (READ MORE: In Health Care, Job Growth Is Not Always Good)
This author does not need to imagine. My wife waited seven months to see her primary doctor for abdominal pain. The diagnosis was inoperable pancreatic cancer. She died 22 months later. Might her cancer have been operable if her wait time had been four days instead of seven months?
Deane Waldman, M.D., MBA is Professor Emeritus of Pediatrics, Pathology, and Decision Science; former Director of the Center for Healthcare Policy at Texas Public Policy Foundation; former Director, New Mexico Health Insurance Exchange; and author of the multi-award winning book Curing the Cancer in U.S. Healthcare: StatesCare and Market-Based Medicine.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














